Elutia, Inc. (ELUT)
0.8392
+0.02
(+2.34%)
USD |
NASDAQ |
Nov 16, 13:48
Elutia Net Income (Quarterly) : -6.503M for Sept. 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | -6.503M |
| June 30, 2026 | -7.646M |
| March 31, 2026 | -7.894M |
| December 31, 2025 | -6.51M |
| September 30, 2025 | -1.044M |
| June 30, 2025 | -7.091M |
| March 31, 2025 | -1.887M |
| December 31, 2024 | -7.155M |
| September 30, 2024 | 3.12M |
| June 30, 2024 | -28.36M |
| March 31, 2024 | -17.99M |
| December 31, 2023 | -15.22M |
| September 30, 2023 | -8.519M |
| June 30, 2023 | -7.73M |
| Date | Value |
|---|---|
| March 31, 2023 | -9.781M |
| December 31, 2022 | -6.015M |
| September 30, 2022 | -11.03M |
| June 30, 2022 | -9.398M |
| March 31, 2022 | -8.149M |
| December 31, 2021 | -9.064M |
| September 30, 2021 | -8.316M |
| June 30, 2021 | -2.385M |
| March 31, 2021 | -5.067M |
| December 31, 2020 | -5.356M |
| September 30, 2020 | -6.731M |
| June 30, 2020 | -5.178M |
| March 31, 2020 | -4.56M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | 1.567M |
| Amgen, Inc. | 3.864B |
| Anika Therapeutics, Inc. | -0.311M |
| BioCryst Pharmaceuticals, Inc. | 37.92M |
| Imunon, Inc. | -3.750M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 1.137M |
| Total Expenses (Quarterly) | 7.64M |
| EPS Diluted (Quarterly) | -0.1468 |
| Enterprise Value | 23.34M |
| Gross Profit Margin (Quarterly) | 61.74% |
| Profit Margin (Quarterly) | -571.9% |
| Earnings Yield | -75.26% |
| Normalized Earnings Yield | -67.25 |